There were 523 press releases posted in the last 24 hours and 166,626 in the last 365 days.

Global Tuberculosis Therapeutics Industry

Tuberculosis Therapeutics market worldwide is projected to grow by US$376. 1 Million, driven by a compounded growth of 4. 9%. Active TB, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.

/EIN News/ -- New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Tuberculosis Therapeutics Industry" - https://www.reportlinker.com/p05818022/?utm_source=GNW
3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$810.1 Million by the year 2025, Active TB will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 3.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$13.2 Million to the region’s size and clout in the next 5 to 6 years. Over US$10.7 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Active TB will reach a market size of US$43.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.9% over the next couple of years and add approximately US$110.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, AstraZeneca PLC; Eli Lilly and Company; GlaxoSmithKline PLC; Johnson & Johnson; Lupin Ltd.; Merck & Co., Inc.; Otsuka Pharmaceutical Co., Ltd.; Panacea Biotec Ltd.; Pfizer, Inc.


Read the full report: https://www.reportlinker.com/p05818022/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Tuberculosis Therapeutics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Tuberculosis Therapeutics Global Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 2: Tuberculosis Therapeutics Global Retrospective Market
Scenario in US$ Thousand by Region/Country: 2009-2017
Table 3: Tuberculosis Therapeutics Market Share Shift across
Key Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Active TB (Disease Type) World Market by
Region/Country in US$ Thousand: 2018 to 2025
Table 5: Active TB (Disease Type) Historic Market Analysis by
Region/Country in US$ Thousand: 2009 to 2017
Table 6: Active TB (Disease Type) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Latent TB (Disease Type) Potential Growth Markets
Worldwide in US$ Thousand: 2018 to 2025
Table 8: Latent TB (Disease Type) Historic Market Perspective
by Region/Country in US$ Thousand: 2009 to 2017
Table 9: Latent TB (Disease Type) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: First-Line Therapy (Therapy) Geographic Market Spread
Worldwide in US$ Thousand: 2018 to 2025
Table 11: First-Line Therapy (Therapy) Region Wise Breakdown of
Global Historic Demand in US$ Thousand: 2009 to 2017
Table 12: First-Line Therapy (Therapy) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 13: Second-Line Therapy (Therapy) World Market Estimates
and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
Table 14: Second-Line Therapy (Therapy) Market Historic Review
by Region/Country in US$ Thousand: 2009 to 2017
Table 15: Second-Line Therapy (Therapy) Market Share Breakdown
by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Tuberculosis Therapeutics Market Share (in %) by Company:
2019 & 2025
Table 16: United States Tuberculosis Therapeutics Market
Estimates and Projections in US$ Thousand by Disease Type: 2018
to 2025
Table 17: Tuberculosis Therapeutics Market in the United States
by Disease Type: A Historic Review in US$ Thousand for
2009-2017
Table 18: United States Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 19: United States Tuberculosis Therapeutics Market
Estimates and Projections in US$ Thousand by Therapy: 2018 to
2025
Table 20: Tuberculosis Therapeutics Market in the United States
by Therapy: A Historic Review in US$ Thousand for 2009-2017
Table 21: United States Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
CANADA
Table 22: Canadian Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Disease Type: 2018 to 2025
Table 23: Canadian Tuberculosis Therapeutics Historic Market
Review by Disease Type in US$ Thousand: 2009-2017
Table 24: Tuberculosis Therapeutics Market in Canada:
Percentage Share Breakdown of Sales by Disease Type for 2009,
2019, and 2025
Table 25: Canadian Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Therapy: 2018 to 2025
Table 26: Canadian Tuberculosis Therapeutics Historic Market
Review by Therapy in US$ Thousand: 2009-2017
Table 27: Tuberculosis Therapeutics Market in Canada:
Percentage Share Breakdown of Sales by Therapy for 2009, 2019,
and 2025
JAPAN
Table 28: Japanese Market for Tuberculosis Therapeutics: Annual
Sales Estimates and Projections in US$ Thousand by Disease Type
for the Period 2018-2025
Table 29: Tuberculosis Therapeutics Market in Japan: Historic
Sales Analysis in US$ Thousand by Disease Type for the Period
2009-2017
Table 30: Japanese Tuberculosis Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 31: Japanese Market for Tuberculosis Therapeutics: Annual
Sales Estimates and Projections in US$ Thousand by Therapy for
the Period 2018-2025
Table 32: Tuberculosis Therapeutics Market in Japan: Historic
Sales Analysis in US$ Thousand by Therapy for the Period
2009-2017
Table 33: Japanese Tuberculosis Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
CHINA
Table 34: Chinese Tuberculosis Therapeutics Market Growth
Prospects in US$ Thousand by Disease Type for the Period
2018-2025
Table 35: Tuberculosis Therapeutics Historic Market Analysis in
China in US$ Thousand by Disease Type: 2009-2017
Table 36: Chinese Tuberculosis Therapeutics Market by Disease
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 37: Chinese Tuberculosis Therapeutics Market Growth
Prospects in US$ Thousand by Therapy for the Period 2018-2025
Table 38: Tuberculosis Therapeutics Historic Market Analysis in
China in US$ Thousand by Therapy: 2009-2017
Table 39: Chinese Tuberculosis Therapeutics Market by Therapy:
Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Tuberculosis Therapeutics Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 40: European Tuberculosis Therapeutics Market Demand
Scenario in US$ Thousand by Region/Country: 2018-2025
Table 41: Tuberculosis Therapeutics Market in Europe: A
Historic Market Perspective in US$ Thousand by Region/Country
for the Period 2009-2017
Table 42: European Tuberculosis Therapeutics Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 43: European Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Disease Type: 2018-2025
Table 44: Tuberculosis Therapeutics Market in Europe in US$
Thousand by Disease Type: A Historic Review for the Period
2009-2017
Table 45: European Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 46: European Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Therapy: 2018-2025
Table 47: Tuberculosis Therapeutics Market in Europe in US$
Thousand by Therapy: A Historic Review for the Period 2009-2017
Table 48: European Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
FRANCE
Table 49: Tuberculosis Therapeutics Market in France by Disease
Type: Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 50: French Tuberculosis Therapeutics Historic Market
Scenario in US$ Thousand by Disease Type: 2009-2017
Table 51: French Tuberculosis Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 52: Tuberculosis Therapeutics Market in France by
Therapy: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 53: French Tuberculosis Therapeutics Historic Market
Scenario in US$ Thousand by Therapy: 2009-2017
Table 54: French Tuberculosis Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
GERMANY
Table 55: Tuberculosis Therapeutics Market in Germany: Recent
Past, Current and Future Analysis in US$ Thousand by Disease
Type for the Period 2018-2025
Table 56: German Tuberculosis Therapeutics Historic Market
Analysis in US$ Thousand by Disease Type: 2009-2017
Table 57: German Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 58: Tuberculosis Therapeutics Market in Germany: Recent
Past, Current and Future Analysis in US$ Thousand by Therapy
for the Period 2018-2025
Table 59: German Tuberculosis Therapeutics Historic Market
Analysis in US$ Thousand by Therapy: 2009-2017
Table 60: German Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
ITALY
Table 61: Italian Tuberculosis Therapeutics Market Growth
Prospects in US$ Thousand by Disease Type for the Period
2018-2025
Table 62: Tuberculosis Therapeutics Historic Market Analysis in
Italy in US$ Thousand by Disease Type: 2009-2017
Table 63: Italian Tuberculosis Therapeutics Market by Disease
Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 64: Italian Tuberculosis Therapeutics Market Growth
Prospects in US$ Thousand by Therapy for the Period 2018-2025
Table 65: Tuberculosis Therapeutics Historic Market Analysis in
Italy in US$ Thousand by Therapy: 2009-2017
Table 66: Italian Tuberculosis Therapeutics Market by Therapy:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 67: United Kingdom Market for Tuberculosis Therapeutics:
Annual Sales Estimates and Projections in US$ Thousand by
Disease Type for the Period 2018-2025
Table 68: Tuberculosis Therapeutics Market in the United
Kingdom: Historic Sales Analysis in US$ Thousand by Disease
Type for the Period 2009-2017
Table 69: United Kingdom Tuberculosis Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 70: United Kingdom Market for Tuberculosis Therapeutics:
Annual Sales Estimates and Projections in US$ Thousand by
Therapy for the Period 2018-2025
Table 71: Tuberculosis Therapeutics Market in the United
Kingdom: Historic Sales Analysis in US$ Thousand by Therapy for
the Period 2009-2017
Table 72: United Kingdom Tuberculosis Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
SPAIN
Table 73: Spanish Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Disease Type: 2018 to 2025
Table 74: Spanish Tuberculosis Therapeutics Historic Market
Review by Disease Type in US$ Thousand: 2009-2017
Table 75: Tuberculosis Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Disease Type for 2009, 2019, and
2025
Table 76: Spanish Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Therapy: 2018 to 2025
Table 77: Spanish Tuberculosis Therapeutics Historic Market
Review by Therapy in US$ Thousand: 2009-2017
Table 78: Tuberculosis Therapeutics Market in Spain: Percentage
Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
RUSSIA
Table 79: Russian Tuberculosis Therapeutics Market Estimates
and Projections in US$ Thousand by Disease Type: 2018 to 2025
Table 80: Tuberculosis Therapeutics Market in Russia by Disease
Type: A Historic Review in US$ Thousand for 2009-2017
Table 81: Russian Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 82: Russian Tuberculosis Therapeutics Market Estimates
and Projections in US$ Thousand by Therapy: 2018 to 2025
Table 83: Tuberculosis Therapeutics Market in Russia by
Therapy: A Historic Review in US$ Thousand for 2009-2017
Table 84: Russian Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 85: Rest of Europe Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Disease Type:
2018-2025
Table 86: Tuberculosis Therapeutics Market in Rest of Europe in
US$ Thousand by Disease Type: A Historic Review for the Period
2009-2017
Table 87: Rest of Europe Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 88: Rest of Europe Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Therapy: 2018-2025
Table 89: Tuberculosis Therapeutics Market in Rest of Europe in
US$ Thousand by Therapy: A Historic Review for the Period
2009-2017
Table 90: Rest of Europe Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 91: Asia-Pacific Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Region/Country:
2018-2025
Table 92: Tuberculosis Therapeutics Market in Asia-Pacific:
Historic Market Analysis in US$ Thousand by Region/Country for
the Period 2009-2017
Table 93: Asia-Pacific Tuberculosis Therapeutics Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 94: Tuberculosis Therapeutics Market in Asia-Pacific by
Disease Type: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 95: Asia-Pacific Tuberculosis Therapeutics Historic
Market Scenario in US$ Thousand by Disease Type: 2009-2017
Table 96: Asia-Pacific Tuberculosis Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 97: Tuberculosis Therapeutics Market in Asia-Pacific by
Therapy: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 98: Asia-Pacific Tuberculosis Therapeutics Historic
Market Scenario in US$ Thousand by Therapy: 2009-2017
Table 99: Asia-Pacific Tuberculosis Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
AUSTRALIA
Table 100: Tuberculosis Therapeutics Market in Australia:
Recent Past, Current and Future Analysis in US$ Thousand by
Disease Type for the Period 2018-2025
Table 101: Australian Tuberculosis Therapeutics Historic Market
Analysis in US$ Thousand by Disease Type: 2009-2017
Table 102: Australian Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 103: Tuberculosis Therapeutics Market in Australia:
Recent Past, Current and Future Analysis in US$ Thousand by
Therapy for the Period 2018-2025
Table 104: Australian Tuberculosis Therapeutics Historic Market
Analysis in US$ Thousand by Therapy: 2009-2017
Table 105: Australian Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
INDIA
Table 106: Indian Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Disease Type: 2018 to 2025
Table 107: Indian Tuberculosis Therapeutics Historic Market
Review by Disease Type in US$ Thousand: 2009-2017
Table 108: Tuberculosis Therapeutics Market in India:
Percentage Share Breakdown of Sales by Disease Type for 2009,
2019, and 2025
Table 109: Indian Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Therapy: 2018 to 2025
Table 110: Indian Tuberculosis Therapeutics Historic Market
Review by Therapy in US$ Thousand: 2009-2017
Table 111: Tuberculosis Therapeutics Market in India:
Percentage Share Breakdown of Sales by Therapy for 2009, 2019,
and 2025
SOUTH KOREA
Table 112: Tuberculosis Therapeutics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Thousand by
Disease Type for the Period 2018-2025
Table 113: South Korean Tuberculosis Therapeutics Historic
Market Analysis in US$ Thousand by Disease Type: 2009-2017
Table 114: Tuberculosis Therapeutics Market Share Distribution
in South Korea by Disease Type: 2009 VS 2019 VS 2025
Table 115: Tuberculosis Therapeutics Market in South Korea:
Recent Past, Current and Future Analysis in US$ Thousand by
Therapy for the Period 2018-2025
Table 116: South Korean Tuberculosis Therapeutics Historic
Market Analysis in US$ Thousand by Therapy: 2009-2017
Table 117: Tuberculosis Therapeutics Market Share Distribution
in South Korea by Therapy: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 118: Rest of Asia-Pacific Market for Tuberculosis
Therapeutics: Annual Sales Estimates and Projections in US$
Thousand by Disease Type for the Period 2018-2025
Table 119: Tuberculosis Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Thousand by
Disease Type for the Period 2009-2017
Table 120: Rest of Asia-Pacific Tuberculosis Therapeutics
Market Share Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 121: Rest of Asia-Pacific Market for Tuberculosis
Therapeutics: Annual Sales Estimates and Projections in US$
Thousand by Therapy for the Period 2018-2025
Table 122: Tuberculosis Therapeutics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Thousand by
Therapy for the Period 2009-2017
Table 123: Rest of Asia-Pacific Tuberculosis Therapeutics
Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 124: Latin American Tuberculosis Therapeutics Market
Trends by Region/Country in US$ Thousand: 2018-2025
Table 125: Tuberculosis Therapeutics Market in Latin America in
US$ Thousand by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 126: Latin American Tuberculosis Therapeutics Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 127: Latin American Tuberculosis Therapeutics Market
Growth Prospects in US$ Thousand by Disease Type for the Period
2018-2025
Table 128: Tuberculosis Therapeutics Historic Market Analysis
in Latin America in US$ Thousand by Disease Type: 2009-2017
Table 129: Latin American Tuberculosis Therapeutics Market by
Disease Type: Percentage Breakdown of Sales for 2009, 2019, and
2025
Table 130: Latin American Tuberculosis Therapeutics Market
Growth Prospects in US$ Thousand by Therapy for the Period
2018-2025
Table 131: Tuberculosis Therapeutics Historic Market Analysis
in Latin America in US$ Thousand by Therapy: 2009-2017
Table 132: Latin American Tuberculosis Therapeutics Market by
Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 133: Argentinean Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Disease Type:
2018-2025
Table 134: Tuberculosis Therapeutics Market in Argentina in US$
Thousand by Disease Type: A Historic Review for the Period
2009-2017
Table 135: Argentinean Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 136: Argentinean Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Therapy: 2018-2025
Table 137: Tuberculosis Therapeutics Market in Argentina in US$
Thousand by Therapy: A Historic Review for the Period 2009-2017
Table 138: Argentinean Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
BRAZIL
Table 139: Tuberculosis Therapeutics Market in Brazil by
Disease Type: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 140: Brazilian Tuberculosis Therapeutics Historic Market
Scenario in US$ Thousand by Disease Type: 2009-2017
Table 141: Brazilian Tuberculosis Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 142: Tuberculosis Therapeutics Market in Brazil by
Therapy: Estimates and Projections in US$ Thousand for the
Period 2018-2025
Table 143: Brazilian Tuberculosis Therapeutics Historic Market
Scenario in US$ Thousand by Therapy: 2009-2017
Table 144: Brazilian Tuberculosis Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
MEXICO
Table 145: Tuberculosis Therapeutics Market in Mexico: Recent
Past, Current and Future Analysis in US$ Thousand by Disease
Type for the Period 2018-2025
Table 146: Mexican Tuberculosis Therapeutics Historic Market
Analysis in US$ Thousand by Disease Type: 2009-2017
Table 147: Mexican Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 148: Tuberculosis Therapeutics Market in Mexico: Recent
Past, Current and Future Analysis in US$ Thousand by Therapy
for the Period 2018-2025
Table 149: Mexican Tuberculosis Therapeutics Historic Market
Analysis in US$ Thousand by Therapy: 2009-2017
Table 150: Mexican Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 151: Rest of Latin America Tuberculosis Therapeutics
Market Estimates and Projections in US$ Thousand by Disease
Type: 2018 to 2025
Table 152: Tuberculosis Therapeutics Market in Rest of Latin
America by Disease Type: A Historic Review in US$ Thousand for
2009-2017
Table 153: Rest of Latin America Tuberculosis Therapeutics
Market Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 154: Rest of Latin America Tuberculosis Therapeutics
Market Estimates and Projections in US$ Thousand by Therapy:
2018 to 2025
Table 155: Tuberculosis Therapeutics Market in Rest of Latin
America by Therapy: A Historic Review in US$ Thousand for
2009-2017
Table 156: Rest of Latin America Tuberculosis Therapeutics
Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 157: The Middle East Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Region/Country:
2018-2025
Table 158: Tuberculosis Therapeutics Market in the Middle East
by Region/Country in US$ Thousand: 2009-2017
Table 159: The Middle East Tuberculosis Therapeutics Market
Share Breakdown by Region/Country: 2009, 2019, and 2025
Table 160: The Middle East Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Disease Type: 2018
to 2025
Table 161: The Middle East Tuberculosis Therapeutics Historic
Market by Disease Type in US$ Thousand: 2009-2017
Table 162: Tuberculosis Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Disease Type for 2009,
2019, and 2025
Table 163: The Middle East Tuberculosis Therapeutics Market
Estimates and Forecasts in US$ Thousand by Therapy: 2018 to
2025
Table 164: The Middle East Tuberculosis Therapeutics Historic
Market by Therapy in US$ Thousand: 2009-2017
Table 165: Tuberculosis Therapeutics Market in the Middle East:
Percentage Share Breakdown of Sales by Therapy for 2009, 2019,
and 2025
IRAN
Table 166: Iranian Market for Tuberculosis Therapeutics: Annual
Sales Estimates and Projections in US$ Thousand by Disease Type
for the Period 2018-2025
Table 167: Tuberculosis Therapeutics Market in Iran: Historic
Sales Analysis in US$ Thousand by Disease Type for the Period
2009-2017
Table 168: Iranian Tuberculosis Therapeutics Market Share
Analysis by Disease Type: 2009 VS 2019 VS 2025
Table 169: Iranian Market for Tuberculosis Therapeutics: Annual
Sales Estimates and Projections in US$ Thousand by Therapy for
the Period 2018-2025
Table 170: Tuberculosis Therapeutics Market in Iran: Historic
Sales Analysis in US$ Thousand by Therapy for the Period
2009-2017
Table 171: Iranian Tuberculosis Therapeutics Market Share
Analysis by Therapy: 2009 VS 2019 VS 2025
ISRAEL
Table 172: Israeli Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Disease Type: 2018-2025
Table 173: Tuberculosis Therapeutics Market in Israel in US$
Thousand by Disease Type: A Historic Review for the Period
2009-2017
Table 174: Israeli Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 175: Israeli Tuberculosis Therapeutics Market Estimates
and Forecasts in US$ Thousand by Therapy: 2018-2025
Table 176: Tuberculosis Therapeutics Market in Israel in US$
Thousand by Therapy: A Historic Review for the Period 2009-2017
Table 177: Israeli Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 178: Saudi Arabian Tuberculosis Therapeutics Market
Growth Prospects in US$ Thousand by Disease Type for the Period
2018-2025
Table 179: Tuberculosis Therapeutics Historic Market Analysis
in Saudi Arabia in US$ Thousand by Disease Type: 2009-2017
Table 180: Saudi Arabian Tuberculosis Therapeutics Market by
Disease Type: Percentage Breakdown of Sales for 2009, 2019, and
2025
Table 181: Saudi Arabian Tuberculosis Therapeutics Market
Growth Prospects in US$ Thousand by Therapy for the Period
2018-2025
Table 182: Tuberculosis Therapeutics Historic Market Analysis
in Saudi Arabia in US$ Thousand by Therapy: 2009-2017
Table 183: Saudi Arabian Tuberculosis Therapeutics Market by
Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 184: Tuberculosis Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Thousand by Disease Type for the Period 2018-2025
Table 185: United Arab Emirates Tuberculosis Therapeutics
Historic Market Analysis in US$ Thousand by Disease Type:
2009-2017
Table 186: Tuberculosis Therapeutics Market Share Distribution
in United Arab Emirates by Disease Type: 2009 VS 2019 VS 2025
Table 187: Tuberculosis Therapeutics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Thousand by Therapy for the Period 2018-2025
Table 188: United Arab Emirates Tuberculosis Therapeutics
Historic Market Analysis in US$ Thousand by Therapy: 2009-2017
Table 189: Tuberculosis Therapeutics Market Share Distribution
in United Arab Emirates by Therapy: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 190: Tuberculosis Therapeutics Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Thousand
by Disease Type for the Period 2018-2025
Table 191: Rest of Middle East Tuberculosis Therapeutics
Historic Market Analysis in US$ Thousand by Disease Type:
2009-2017
Table 192: Rest of Middle East Tuberculosis Therapeutics Market
Share Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 193: Tuberculosis Therapeutics Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Thousand
by Therapy for the Period 2018-2025
Table 194: Rest of Middle East Tuberculosis Therapeutics
Historic Market Analysis in US$ Thousand by Therapy: 2009-2017
Table 195: Rest of Middle East Tuberculosis Therapeutics Market
Share Breakdown by Therapy: 2009 VS 2019 VS 2025
AFRICA
Table 196: African Tuberculosis Therapeutics Market Estimates
and Projections in US$ Thousand by Disease Type: 2018 to 2025
Table 197: Tuberculosis Therapeutics Market in Africa by
Disease Type: A Historic Review in US$ Thousand for 2009-2017
Table 198: African Tuberculosis Therapeutics Market Share
Breakdown by Disease Type: 2009 VS 2019 VS 2025
Table 199: African Tuberculosis Therapeutics Market Estimates
and Projections in US$ Thousand by Therapy: 2018 to 2025
Table 200: Tuberculosis Therapeutics Market in Africa by
Therapy: A Historic Review in US$ Thousand for 2009-2017
Table 201: African Tuberculosis Therapeutics Market Share
Breakdown by Therapy: 2009 VS 2019 VS 2025

IV. COMPETITION

ASTRAZENECA PLC
ELI LILLY AND COMPANY
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
LUPIN LTD.
MERCK & CO., INC.
OTSUKA PHARMACEUTICAL CO., LTD.
PANACEA BIOTEC LTD.
PFIZER, INC

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05818022/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
Distribution channels: Media, Advertising & PR


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.